HSU JASON received a stock award from IMMIX BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/29/2026ACC: 0001493152-26-026422
+18.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
18.75K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.25K
Price / share
—
Trade value
—
% of position
0.7%
5/22/2026
893K→899.25K
Total
Net shares
+6.25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/22/2026 | A · Award | +6.25K | — | — | 0.7% | 893K | 899.25K |
| Total | +6.25K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
12.50K shares
Shares
+12.50K
Strike price
8.78
Held after
12.50K
Exercisable
—
5/22/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock12.50K shares | 5/22/2026 | A · Award | +12.50K | 8.78 | — | 12.50K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned3.92M
Common Stock
IndirectShares owned50K
Total
3.97M indirect3.97M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.92M | Indirect |
| Common Stock | 50K | Indirect |
| Total | 3.97M | 3.97M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported